Avalo Therapeutics
AVTX
AVTX
18 hedge funds and large institutions have $72.3M invested in Avalo Therapeutics in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$431K | |
| 2 | +$315K | |
| 3 | +$184K | |
| 4 |
DBIA
Dumont & Blake Investment Advisors
Princeton,
New Jersey
|
+$129K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$85.9K |
Top Sellers
| 1 | -$682K | |
| 2 | -$74K | |
| 3 | -$32K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$24.6K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$24.1K |